Abstract
Background
Specific patterns of metabolomic profiles relating to cardiometabolic disease are associated with increased weight in adults. In youth with obesity, metabolomic data are sparse and associations with adiposity measures unknown.
Objectives
Primary, to determine associations between adiposity measures and metabolomic profiles with increased cardiometabolic risks in youth with obesity. Secondary, to stratify associations by sex and puberty.
Methods
Participants were from COBRA (Childhood Overweight BioRepository of Australia; a paediatric cohort with obesity). Adiposity measures (BMI, BMI z-score, %truncal and %whole body fat, waist circumference and waist/height ratio), puberty staging and NMR metabolomic profiles from serum were assessed. Statistics included multivariate analysis (principal component analysis, PCA) and multiple linear regression models with false discovery rate adjustment.
Results
214 participants had metabolomic profiles analyzed, mean age 11.9 years (SD ± 3.1), mean BMI z-score 2.49 (SD ± 0.24), 53% females. Unsupervised PCA identified no separable clusters of individuals. Positive associations included BMI z-score and phenylalanine, total body fat % and lipids in medium HDL, and waist circumference and tyrosine; negative associations included total body fat % and the ratio of docosahexaenoic acid/total fatty acids and histidine. Stratifying by sex and puberty, patterns of associations with BMI z-score in post-pubertal males included positive associations with lipid-, cholesterol- and triglyceride-content in VLDL lipoproteins; total fatty acids; total triglycerides; isoleucine, leucine and glycoprotein acetyls.
Conclusion
In a paediatric cohort with obesity, increased adiposity measures, especially in post-pubertal males, were associated with distinct patterns in metabolomic profiles.
Similar content being viewed by others
References
Akinkuolie, A. O., Buring, J. E., Ridker, P. M., & Mora, S. (2014). A novel protein glycan biomarker and future cardiovascular disease events. Journal of the American Heart Association, 3, e001221.
Back, M., Yurdagul, A., Jr., Tabas, I., Oorni, K. and Kovanen, P.T. (2019) Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-019-0169-2.
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate—A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B-Methodological, 57, 289–300.
Bjerregaard, L. G., Rasmussen, K. M., Michaelsen, K. F., Skytthe, A., Mortensen, E. L., Baker, J. L., et al. (2014). Effects of body size and change in body size from infancy through childhood on body mass index in adulthood. International Journal of Obesity, 38, 1305–1311.
Butte, N. F., Liu, Y., Zakeri, I. F., Mohney, R. P., Mehta, N., Voruganti, V. S., et al. (2015). Global metabolomic profiling targeting childhood obesity in the Hispanic population. American Journal of Clinical Nutrition, 102, 256–267.
Chen, X., & Wang, Y. (2008). Tracking of blood pressure from childhood to adulthood: A systematic review and meta-regression analysis. Circulation, 117, 3171–3180.
Chung, S. T., Onuzuruike, A. U., & Magge, S. N. (2018). Cardiometabolic risk in obese children. Annals of the New York Academy of Sciences, 1411, 166–183.
David Meyer, E. D., Hornik, K., Weingessel, A., & Leisch, F. (2018). e1071: Misc Functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), TU Wien. R package version 1.7-0.
Fischer, K., Kettunen, J., Wurtz, P., Haller, T., Havulinna, A. S., Kangas, A. J., et al. (2014). Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: An observational study of 17,345 persons. PLoS Med, 11, e1001606.
Gidding, S. S., Nehgme, R., Heise, C., Muscar, C., Linton, A., & Hassink, S. (2004). Severe obesity associated with cardiovascular deconditioning, high prevalence of cardiovascular risk factors, diabetes mellitus/hyperinsulinemia, and respiratory compromise. Journal of Pediatrics, 144, 766–769.
Ho, J. E., Larson, M. G., Ghorbani, A., Cheng, S., Chen, M. H., Keyes, M., et al. (2016). Metabolomic profiles of body mass index in the framingham heart study reveal distinct cardiometabolic phenotypes. PLoS ONE, 11, e0148361.
Holmes, M. V., Lange, L. A., Palmer, T., Lanktree, M. B., North, K. E., Almoguera, B., et al. (2014). Causal effects of body mass index on cardiometabolic traits and events: A Mendelian randomization analysis. American Journal of Human Genetics, 94, 198–208.
Holmes, M. V., Millwood, I. Y., Kartsonaki, C., Hill, M. R., Bennett, D. A., Boxall, R., et al. (2018). Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. Journal of the American College of Cardiology, 71, 620–632.
Juhola, J., Magnussen, C. G., Viikari, J. S., Kahonen, M., Hutri-Kahonen, N., Jula, A., et al. (2011). Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. Journal of Pediatrics, 159, 584–590.
Kettunen, J., Tukiainen, T., Sarin, A. P., Ortega-Alonso, A., Tikkanen, E., Lyytikainen, L. P., et al. (2012). Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nature Genetics, 44, 269–276.
Kuczmarski, R. J., Ogden, C. L., Grummer-Strawn, L. M., Flegal, K. M., Guo, S. S., Wei, R., et al. (2000). CDC growth charts: United States. Advanced Data, 314, 1–27.
Lawler, P. R., Akinkuolie, A. O., Chandler, P. D., Moorthy, M. V., Vandenburgh, M. J., Schaumberg, D. A., et al. (2016). Circulating N-linked glycoprotein acetyls and longitudinal mortality risk. Circulation Research, 118, 1106–1115.
Loomba-Albrecht, L. A., & Styne, D. M. (2009). Effect of puberty on body composition. Current opinion in Endocrinology, Diabetes, and Obesity, 16, 10–15.
Lopategi, A., Flores-Costa, R., Rius, B., Lopez-Vicario, C., Alcaraz-Quiles, J., Titos, E., et al. (2019). Frontline science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome. Journal of Leukocyte Biology, 105, 25–36.
Manmadhan, A., Lin, B. X., Zhong, J., Parikh, M., Berger, J. S., Fisher, E. A., et al. (2019). Elevated GlycA in severe obesity is normalized by bariatric surgery. Diabetes, Obesity & Metabolism, 21, 178–182.
Marshall, W. A., & Tanner, J. M. (1969). Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood, 44, 291–303.
Marshall, W. A., & Tanner, J. M. (1970). Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood, 45, 13–23.
May, A. L., Kuklina, E. V., & Yoon, P. W. (2012). Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics, 129, 1035–1041.
McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity, 30, 598–602.
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., et al. (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 384, 766–781.
Norris, A. L., Steinberger, J., Steffen, L. M., Metzig, A. M., Schwarzenberg, S. J., & Kelly, A. S. (2011). Circulating oxidized LDL and inflammation in extreme pediatric obesity. Obesity (Silver Spring), 19, 1415–1419.
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., et al. (2005). A potential decline in life expectancy in the United States in the 21st century. New England Journal of Medicine, 352, 1138–1145.
R Core Team (2018) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
Reinehr, T., Wolters, B., Knop, C., Lass, N., & Holl, R. W. (2015). Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. Journal of Clinical Endocrinology and Metabolism, 100, 301–308.
Sabin, M. A., Clemens, S. L., Saffery, R., McCallum, Z., Campbell, M. W., Kiess, W., et al. (2010). New directions in childhood obesity research: How a comprehensive biorepository will allow better prediction of outcomes. BMC Medical Research Methodology, 10, 100.
Santos-Gallego, C. G. (2015). HDL: Quality or quantity? Atherosclerosis, 243, 121–123.
Soininen, P., Kangas, A. J., Wurtz, P., Tukiainen, T., Tynkkynen, T., Laatikainen, R., et al. (2009). High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst, 134, 1781–1785.
Stancakova, A., Civelek, M., Saleem, N. K., Soininen, P., Kangas, A. J., Cederberg, H., et al. (2012). Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes, 61, 1895–1902.
Tulipani, S., Palau-Rodriguez, M., Minarro Alonso, A., Cardona, F., Marco-Ramell, A., Zonja, B., et al. (2016). Biomarkers of morbid obesity and prediabetes by metabolomic profiling of human discordant phenotypes. Clinica Chimica Acta, 463, 53–61.
Vignoli, A., Tenori, L., Luchinat, C., & Saccenti, E. (2018). Age and sex effects on plasma metabolite association networks in healthy subjects. Journal of Proteome Research, 17, 97–107.
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., et al. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine, 17, 448–453.
Welsh, P., Rankin, N., Li, Q., Mark, P. B., Wurtz, P., Ala-Korpela, M., et al. (2018). Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. Diabetologia, 61, 1581–1591.
Wiklund, P. K., Pekkala, S., Autio, R., Munukka, E., Xu, L., Saltevo, J., et al. (2014). Serum metabolic profiles in overweight and obese women with and without metabolic syndrome. Diabetology & Metabolic Syndrome, 6, 40.
Wishart, D. S. (2016). Emerging applications of metabolomics in drug discovery and precision medicine. Nature Reviews Drug Discovery, 15, 473–484.
Worley, B., & Powers, R. (2013). Multivariate analysis in metabolomics. Current Metabolomics, 1, 92–107.
Wurtz, P., Havulinna, A. S., Soininen, P., Tynkkynen, T., Prieto-Merino, D., Tillin, T., et al. (2015). Metabolite profiling and cardiovascular event risk: A prospective study of 3 population-based cohorts. Circulation, 131, 774–785.
Wurtz, P., Makinen, V. P., Soininen, P., Kangas, A. J., Tukiainen, T., Kettunen, J., et al. (2012a). Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes, 61, 1372–1380.
Wurtz, P., Raiko, J. R., Magnussen, C. G., Soininen, P., Kangas, A. J., Tynkkynen, T., et al. (2012b). High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. European Heart Journal, 33, 2307–2316.
Wurtz, P., Wang, Q., Kangas, A. J., Richmond, R. C., Skarp, J., Tiainen, M., et al. (2014). Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med, 11, e1001765.
Xie, G., Ma, X., Zhao, A., Wang, C., Zhang, Y., Nieman, D., et al. (2014). The metabolite profiles of the obese population are gender-dependent. Journal of Proteome Research, 13, 4062–4073.
Zhang, A., Sun, H., Xu, H., Qiu, S., & Wang, X. (2013). Cell metabolomics. OMICS: A Journal of Integrative Biology, 17, 495–501.
Zhao, X., Han, Q., Liu, Y., Sun, C., Gang, X., & Wang, G. (2016). The relationship between branched-chain amino acid related metabolomic signature and insulin resistance: A systematic review. Journal of Diabetes Research, 2016, 2794591.
Acknowledgements
The authors would like to thank the COBRA participants and their families.
Funding
Authors from the Murdoch Children’s Research Institute are supported in part by the Victorian Government Operational Infrastructure Support Program. CS was supported for a 1 year clinical research fellowship position at the Endocrinology Department at the Royal Children’s Hospital by “Batzebaer Foundation”, Inselspital Bern; “Fondazione Ettore e Valeria Rossi”; “Freie akademische Gesellschaft Basel” and “NovoNordisk”, all Switzerland. CS declares that he has no conflict of interest to declare. BEH is an NHMRC Peter Doherty ECF Fellow (APP: 1072086). BEH declares that he has no conflict of interest to declare. DPB is supported by NHMRC Senior Research Fellowship (1064629) and an Honorary Future Leader Fellowship of the National Heart Foundation of Australia (100369). DPB declares that he has no conflict of interest to declare. MJ was supported by Juho Vainio Foundation and federal research grants to Turku University Hospital. MJ declares that he has no conflict of interest to declare. The funding bodies did not play any role in this study or the decision to publish.
Author information
Authors and Affiliations
Contributions
CS conceptualized the study, undertook statistical analysis and interpreted results and wrote/revised manuscript; BEH conceptualized the study, collected data and analyzed samples and revised manuscript; AP provided statistical support; SE provided statistical support; ZM collected data; KTK initial study design and data collection; CT collected data; AP collected data; EJA collected data; RS assisted with result interpretation and revised manuscript; DPB assisted with result interpretation and revised manuscript; MJ assisted with result interpretation and revised manuscript; MAS set up the cohort, conceptualized the study, interpreted results and revised manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interest to declare.
Ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11306_2019_1537_MOESM2_ESM.pdf
Supplementary material 2 (PDF 22 kb) Supplementary figure 1: Changes in metabolites by 1 SD increase in body mass index, adjusted for age and sex. Legend supplementary figure 1: Changes in mean and 95% confidence interval per 1-SD increase in BMI.* indicate significant associations after multiple regression modelling (p value < 0.05). Estimates and 95% CI’s in bold illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-Hochberg)
11306_2019_1537_MOESM3_ESM.pdf
Supplementary material 3 (PDF 24 kb) Supplementary figure 2: Changes in metabolites by 1 SD increase in total body fat %, adjusted for age and sex. Legend supplementary Figure 2: Changes in mean and 95% confidence interval per 1-SD increase in total body fat %. *indicate significant associations after multiple regression modelling (p-value < 0.05). Estimates and 95% CI’s in bold illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-Hochberg)
11306_2019_1537_MOESM4_ESM.pdf
Supplementary material 4 (PDF 24 kb) Supplementary figure 3: Changes in metabolites by 1 SD increase in truncal fat %, adjusted for age and sex. Legend supplementary figure 3: Changes in mean and 95% confidence interval per 1-SD increase in truncal fat %. * indicate significant associations after multiple regression modelling (p-value < 0.05). Estimates and 95% CI’s in bold illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-Hochberg)
11306_2019_1537_MOESM5_ESM.pdf
Supplementary material 5 (PDF 22 kb) Supplementary figure 4: Changes in metabolites by 1 SD increase in waist circumference, adjusted for age and sex. Legend supplementary figure 4: Changes in mean and 95% confidence interval per 1-SD increase in waist circumference. * indicate significant associations after multiple regression modelling (p-value < 0.05). Estimates and 95% CI’s in bold illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-Hochberg)
11306_2019_1537_MOESM6_ESM.pdf
Supplementary material 6 (PDF 22 kb) Supplementary Fig. 5: Changes in metabolites by 1 SD increase in waist to height ratio, adjusted for age and sex. Legend supplementary Fig. 5: Changes in mean and 95% confidence interval per 1-SD increase in waist to height ratio. * indicate significant associations after multiple regression modelling (p-value < 0.05). Estimates and 95% CI’s in bold illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-Hochberg)
Rights and permissions
About this article
Cite this article
Saner, C., Harcourt, B.E., Pandey, A. et al. Sex and puberty-related differences in metabolomic profiles associated with adiposity measures in youth with obesity. Metabolomics 15, 75 (2019). https://doi.org/10.1007/s11306-019-1537-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-019-1537-y